NCT03347123 2022-02-28A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)Incyte CorporationPhase 1/2 Terminated11 enrolled 12 charts